CONGRESS ASSET MANAGEMENT CO /MA - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
CONGRESS ASSET MANAGEMENT CO /MA ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$3,086,000
-10.8%
32,375
+4.6%
0.03%
-19.5%
Q2 2020$3,461,000
+57.1%
30,947
+2.2%
0.04%
+20.6%
Q1 2020$2,203,000
+10.7%
30,292
+58.8%
0.03%
+41.7%
Q4 2019$1,990,000
-21.8%
19,079
-25.4%
0.02%
-27.3%
Q3 2019$2,545,000
-7.0%
25,563
+6.7%
0.03%
-5.7%
Q2 2019$2,736,000
-2.6%
23,966
+7.2%
0.04%
-5.4%
Q1 2019$2,810,000
-3.2%
22,351
+4.5%
0.04%
-15.9%
Q4 2018$2,903,000
-50.7%
21,393
-0.2%
0.04%
-42.1%
Q3 2018$5,885,000
+30.0%
21,438
-1.9%
0.08%
+22.6%
Q2 2018$4,526,000
+31.5%
21,845
+4.9%
0.06%
+29.2%
Q1 2018$3,441,000
+34.9%
20,833
+11.8%
0.05%
+29.7%
Q4 2017$2,551,000
+26.1%
18,631
+25.4%
0.04%
+19.4%
Q3 2017$2,023,000
+118.2%
14,855
+94.5%
0.03%
+82.4%
Q2 2017$927,000
+36.7%
7,636
+19.3%
0.02%
+30.8%
Q1 2017$678,000
+48.7%
6,403
+42.8%
0.01%
+30.0%
Q4 2016$456,0004,4840.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders